Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3708627015 | Atenolol- and bendroflumethiazide-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3708628013 | Product containing atenolol and bendroflumethiazide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5508601000241114 | produit contenant de l'aténolol et du bendrofluméthiazide sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Atenolol- and bendroflumethiazide-containing product in oral dose form | Is a | Product containing atenolol and bendroflumethiazide (medicinal product) | true | Inferred relationship | Some | ||
Atenolol- and bendroflumethiazide-containing product in oral dose form | Has active ingredient | Bendroflumethiazide (substance) | true | Inferred relationship | Some | 2 | |
Atenolol- and bendroflumethiazide-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Atenolol- and bendroflumethiazide-containing product in oral dose form | Has active ingredient | Atenolol (substance) | true | Inferred relationship | Some | 1 | |
Atenolol- and bendroflumethiazide-containing product in oral dose form | Is a | Atenolol-containing product in oral dose form | true | Inferred relationship | Some | ||
Atenolol- and bendroflumethiazide-containing product in oral dose form | Is a | Bendroflumethiazide-containing product in oral dose form | true | Inferred relationship | Some | ||
Atenolol- and bendroflumethiazide-containing product in oral dose form | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule | Is a | False | Atenolol- and bendroflumethiazide-containing product in oral dose form | Inferred relationship | Some | |
Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form) | Is a | True | Atenolol- and bendroflumethiazide-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets